Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CAMP4 THERAPEUTICS CORPORATION
CAMP
$6.20
Name : CAMP4 THERAPEUTICS CORPORATION
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $321,663,040.00
EPSttm : -10.85
finviz dynamic chart for CAMP
CAMP4 THERAPEUTICS CORPORATION
$6.20
3.51%
$0.21

Float Short %

2.17

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

6.26

Price

0.4

Target Price

8.75

Analyst Recom

1.33

Performance Q

73.62

Relative Volume

0.4

Beta

0.69

Ticker: CAMP



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-08CAMP3.58N/AN/A0
2025-12-09CAMP4.59N/AN/A0
2025-12-10CAMP5.71N/AN/A0
2025-12-11CAMP6.12N/AN/A0
2025-12-12CAMP6.42N/AN/A0
2025-12-15CAMP6.62N/AN/A0
2025-12-16CAMP7N/AN/A0
2025-12-17CAMP7.1N/AN/A0
2025-12-18CAMP6.17N/AN/A0
2025-12-19CAMP6.3N/AN/A0
2025-12-22CAMP6.05N/AN/A0
2025-12-23CAMP5.95N/AN/A0
2025-12-26CAMP5.98N/AN/A0
2025-12-29CAMP6.06N/AN/A0
2025-12-30CAMP5.93N/AN/A0
2025-12-31CAMP6.1N/AN/A0
2026-01-02CAMP6.3N/AN/A0
2026-01-05CAMP5.98N/AN/A0
2026-01-06CAMP5.93N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



No data found



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-08CAMP24.2419.462.34
2025-12-09CAMP24.2419.462.34
2025-12-10CAMP24.2419.462.28
2025-12-11CAMP24.2419.462.28
2025-12-12CAMP24.2419.462.28
2025-12-15CAMP24.2419.462.28
2025-12-16CAMP24.2419.462.28
2025-12-17CAMP24.2419.462.28
2025-12-18CAMP24.2419.462.28
2025-12-19CAMP24.2419.462.28
2025-12-22CAMP21.4017.262.28
2025-12-23CAMP21.4017.262.28
2025-12-26CAMP21.4017.262.25
2025-12-29CAMP21.4017.262.17
2025-12-30CAMP22.0117.262.17
2025-12-31CAMP22.0117.262.17
2026-01-02CAMP22.0117.262.17
2026-01-05CAMP22.0117.262.17
2026-01-06CAMP22.0117.262.17
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-2.04

Avg. EPS Est. Next Quarter

-1.15

Insider Transactions

22.01

Institutional Transactions

17.26

Beta

0.69

Average Sales Estimate Current Quarter

51

Average Sales Estimate Next Quarter

53

Fair Value

Quality Score

22

Growth Score

28

Sentiment Score

11

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

8.75

P/E

Forward P/E

PEG

P/S

81.78

P/B

4.79

P/Free Cash Flow

EPS

-2.45

Average EPS Est. Cur. Y​

-5.27

EPS Next Y. (Est.)

0.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1404.47

Relative Volume

0.4

Return on Equity vs Sector %

84.2

Return on Equity vs Industry %

113.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

CAMP4 THERAPEUTICS CORPORATION
Sector: Healthcare
Industry: Biotechnology
Employees: 55
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
stock quote shares CAMP – CalAmp Corp. Stock Price stock today
news today CAMP – CalAmp Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch CAMP – CalAmp Corp. yahoo finance google finance
stock history CAMP – CalAmp Corp. invest stock market
stock prices CAMP premarket after hours
ticker CAMP fair value insiders trading